Which medication is classified as a LABA?

A medication classified as a Long-Acting Beta Agonist (LABA) is one that selectively stimulates beta-2 adrenergic receptors in the lungs, leading to bronchodilation and sustained relief from symptoms associated with asthma and Chronic Obstructive Pulmonary Disease (COPD).

Olodaterol is a LABA that specifically fits this classification. It is designed for once-daily dosing and works by relaxing the muscles in the airways, making it easier for patients to breathe. This long duration of action helps in managing chronic respiratory conditions effectively, as it provides ongoing control of bronchoconstriction.

In contrast, the other options listed do not belong to the LABA category. Aclidinium and Umeclidinium are classified as long-acting muscarinic antagonists (LAMAs) that block muscarinic receptors, while Ipratropium is a short-acting muscarinic antagonist (SAMA). These medications work differently compared to LABAs, primarily affecting the cholinergic pathways rather than directly stimulating adrenergic receptors in the lungs. Hence, they serve different therapeutic roles in the management of respiratory conditions.